查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387430

牛流行病热 (BEF) 疫苗市场报告：2030 年趋势、预测和竞争分析

Bavine Ephermal Fever Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

牛流行病热 (BEF) 疫苗趋势和预测

预计 2024 年至 2030 年，全球牛流行病热 (BEF) 疫苗市场将以 7.0% 的年复合成长率成长。该市场的主要驱动因素是偶发性牛热病例数量的增加、疫苗生产技术的发展以及製药公司需求的增加。全球牛流行病热（BEF）疫苗市场前景广阔，医疗设备公司、製药业、兽医院市场蕴藏商机。

牛流行病热 (BEF) 疫苗市场洞察

Lucintel 预测，由于世界范围内偶发性牛的高发生率和牛的数量，牛在预测期内将经历最大的增长。

由于许多公司大力投资兽用疫苗的研发，预计北美在预测期内将出现最高的成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球牛流行病（BEF）疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球牛流行病（BEF）疫苗市场趋势（2018-2023）及预测（2024-2030）
  • 按类型分類的全球牛流行病热 (BEF) 疫苗市场
    • 活病毒疫苗
    • 灭活疫苗
    • 其他的
  • 全球牛流行病热 (BEF) 疫苗市场（按应用）
    • 牛
    • 水牛
    • 其他的
  • 全球牛流行病热 (BEF) 疫苗市场（按最终用途）
    • 医疗设备公司
    • 製药业
    • 动物医院
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球牛流行病热（BEF）疫苗市场区域分布
  • 北美牛流行病（BEF）疫苗市场
  • 欧洲牛流行病热（BEF）疫苗市场
  • 亚太地区牛流行病（BEF）疫苗市场
  • 其他地区牛流行病（BEF）疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球牛流行病热 (BEF) 疫苗市场成长机会（按类型）
    • 全球牛流行病热 (BEF) 疫苗市场成长机会（按应用）
    • 全球牛流行病热 (BEF) 疫苗市场成长机会（按最终用途）
    • 全球牛流行病热（BEF）疫苗市场成长机会（按地区）
  • 全球牛流行病热（BEF）疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球牛流行病热 (BEF) 疫苗市场产能扩张
    • 全球牛流行病热（BEF）疫苗市场的合併、收购与合资
    • 认证和许可

第7章主要企业概况

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals
简介目录

Bavine Ephermal Fever Vaccine Trends and Forecast

The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets. The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

A more than 150-page report is developed to help in your business decisions.

Bavine Ephermal Fever Vaccine by Segment

The study includes a forecast for the global bavine ephermal fever vaccine by type, application, end use, and region.

Bavine Ephermal Fever Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Live Vaccines
  • Killed Vaccines
  • Others

Bavine Ephermal Fever Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cattle
  • Water Buffaloes
  • Others

Bavine Ephermal Fever Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Medical Device Companies
  • Pharmaceutical Industries
  • Animal Hospitals
  • Others

Bavine Ephermal Fever Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bavine Ephermal Fever Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bavine ephermal fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bavine ephermal fever vaccine companies profiled in this report include-

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals

Bavine Ephermal Fever Vaccine Market Insights

Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Features of the Global Bavine Ephermal Fever Vaccine Market

Market Size Estimates: Bavine ephermal fever vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bavine ephermal fever vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bavine ephermal fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the bavine ephermal fever vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bavine ephermal fever vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bavine ephermal fever vaccine market?

Answer: The global bavine ephermal fever vaccine market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bavine ephermal fever vaccine market?

Answer: The major drivers for this market are growing number of cases of transient bovine fever, technological developments in the creation of vaccines , and rising demand for pharmaceutical companies.

Q3. What are the major segments for bavine ephermal fever vaccine market?

Answer: The future of the global bavine ephermal fever vaccine market looks promising with opportunities in the medical device companies, pharmaceutical industries, and animal hospitals markets.

Q4. Who are the key bavine ephermal fever vaccine market companies?

Answer: Some of the key bavine ephermal fever vaccine companies are as follows:

  • Zoetis Services
  • Nutri Pharmax
  • Octavoscene
  • Kyoto Biken Laboratories
  • Indian Immunologicals

Q5. Which bavine ephermal fever vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cattle is expected to witness largest growth over the forecast period due to high prevalence of bovine ephemeral fever in cattle and large population of cattle worldwide.

Q6. In bavine ephermal fever vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness largest growth over the forecast period due to growing presence of large number of companies with large investment of research and development of vaccines for animal health care.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bavine ephermal fever vaccine market by type (live vaccines, killed vaccines, and others), application (cattle, water buffaloes, and others), end use (medical device companies, pharmaceutical industries, animal hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bavine Ephermal Fever Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bavine Ephermal Fever Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bavine Ephermal Fever Vaccine Market by Type
    • 3.3.1: Live Vaccines
    • 3.3.2: Killed Vaccines
    • 3.3.3: Others
  • 3.4: Global Bavine Ephermal Fever Vaccine Market by Application
    • 3.4.1: Cattle
    • 3.4.2: Water Buffaloes
    • 3.4.3: Others
  • 3.5: Global Bavine Ephermal Fever Vaccine Market by End Use
    • 3.5.1: Medical Device Companies
    • 3.5.2: Pharmaceutical Industries
    • 3.5.3: Animal Hospitals
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bavine Ephermal Fever Vaccine Market by Region
  • 4.2: North American Bavine Ephermal Fever Vaccine Market
    • 4.2.2: North American Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.3: European Bavine Ephermal Fever Vaccine Market
    • 4.3.1: European Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.3.2: European Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.4: APAC Bavine Ephermal Fever Vaccine Market
    • 4.4.1: APAC Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.4.2: APAC Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others
  • 4.5: ROW Bavine Ephermal Fever Vaccine Market
    • 4.5.1: ROW Bavine Ephermal Fever Vaccine Market by Application: Cattle, Water Buffaloes, and Others
    • 4.5.2: ROW Bavine Ephermal Fever Vaccine Market by End Use: Medical Device Companies, Pharmaceutical Industries, Animal Hospitals, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bavine Ephermal Fever Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Bavine Ephermal Fever Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bavine Ephermal Fever Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bavine Ephermal Fever Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zoetis Services
  • 7.2: Nutri Pharmax
  • 7.3: Octavoscene
  • 7.4: Kyoto Biken Laboratories
  • 7.5: Indian Immunologicals